Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$19.73 -0.58 (-2.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Sale and Maturity of Investments (2010 - 2026)

Updated

Analysis

Acadia Pharmaceuticals (ACAD) Sale and Maturity of Investments (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Acadia Pharmaceuticals 3.40 Bn -78.46 Mn 279.64 Mn 90.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.00 Mn
Mar 31, 2026 86.50 Mn
Dec 31, 2025 105.75 Mn
Sep 30, 2025 125.59 Mn
Jun 30, 2025 131.39 Mn
Mar 31, 2025 130.80 Mn
Dec 31, 2024 111.85 Mn
Sep 30, 2024 69.10 Mn
Jun 30, 2024 81.50 Mn
Mar 31, 2024 66.12 Mn
Dec 31, 2023 103.76 Mn
Sep 30, 2023 59.11 Mn
Jun 30, 2023 7.50 Mn
Mar 31, 2023 259.41 Mn
Dec 31, 2022 75.80 Mn
Sep 30, 2022 159.69 Mn
Jun 30, 2022 69.58 Mn
Mar 31, 2022 131.35 Mn
Dec 31, 2021 110.50 Mn
Sep 30, 2021 95.00 Mn
API Access

Acadia Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ACAD&period=max&api_key=YOUR_API_KEY